We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+0.19%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$307B
AUM Growth
+$12.5B
Cap. Flow
+$15.6B
Cap. Flow %
5.07%
Top 10 Hldgs %
16.91%
Holding
4,157
New
131
Increased
2,872
Reduced
471
Closed
108

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$442M
2
AMZN icon
Amazon
AMZN
+$347M
3
AAPL icon
Apple
AAPL
+$276M
4
INTC icon
Intel
INTC
+$246M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$231M

Sector Composition

Rank Sector Weight
1 Technology 17.82%
2 Financials 16.57%
3 Healthcare 13.16%
4 Industrials 10.29%
5 Consumer Discretionary 9.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HSNI
4101
DELISTED
HSN, Inc.
HSNI
-251,255
Closed -$10.1M
XBKS
4102
DELISTED
Xenith Bankshares, Inc. Common Stock
XBKS
-99,335
Closed -$3.36M
IMUC
4103
DELISTED
ImmunoCellular Therapeutics, Ltd.
IMUC
-10,995
Closed -$3K
ARGS
4104
DELISTED
Argos Therapeutics, Inc.
ARGS
-5,750
Closed -$17K
OREX
4105
DELISTED
Orexigen Therapeutics, Inc.
OREX
-59,849
Closed -$77K
SNBC
4106
DELISTED
Sun Bancorp Inc
SNBC
-100,023
Closed -$2.43M
BOBE
4107
DELISTED
Bob Evans Farms, Inc.
BOBE
-177,917
Closed -$14M
WES
4108
DELISTED
Western Gas Partners Lp
WES
-4,659
Closed -$224K
RPRX
4109
DELISTED
Repros Therapeutics Inc.
RPRX
-131,112
Closed -$86K

Similar funds

Geode Capital Management's Q1 2018 Portfolio in Review

As of Q1 2018, Geode Capital Management held 4,157 positions worth $307B, up 4.2% from $294B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Geode Capital Management deployed $15.6B of net new capital in Q1 2018, opening 131 new positions and adding to 2,872 existing holdings. Its largest new stake was GCI Liberty, Inc. Class A Common Stock (DE): 899,850 shares worth $47.6M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Enbridge, an estimated $27.1M trimmed.

  • Geode Capital Management's largest Q1 2018 buy was GCI Liberty, Inc. Class A Common Stock (DE): 899,850 shares worth $47.6M.
  • Geode Capital Management added most to Microsoft in Q1 2018, an estimated $442M increase.
  • Geode Capital Management's biggest Q1 2018 reduction was Enbridge, cutting an estimated $27.1M.
  • Geode Capital Management fully exited Scripps Networks Interactive, Inc Common Class A in Q1 2018, selling an estimated $90M.
  • Geode Capital Management's ten largest holdings make up 17% of its $307B portfolio in Q1 2018.
  • Geode Capital Management opened 131 new positions and closed 108 in Q1 2018.
  • Geode Capital Management's portfolio value rose 4.2% quarter-over-quarter to $307B.

Based on Geode Capital Management's 13F filing for Q1 2018, filed 15 May 2018.